HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

QSAR analysis of substituted bis[(acridine-4-carboxamide)propyl]methylamines using optimized block-wise variable combination by particle swarm optimization for partial least squares modeling.

Abstract
In the current work, we employed optimized block-wise variable combination (OBVC) by particle swarm optimization (PSO) based on partial least squares (PLS) modeling for variable combination and compared it to the traditional methods. It has been demonstrated that the modified PSO is a useful tool for searching optimized variable combination. Quantitative structure-activity relationship (QSAR) model has been formulated for a set of DNA binding topoisomerase (topo) (substituted bis[(acridine-4-carboxamide)propyl]methylamines) on murine Lewis lung carcinoma (LL(c)) cells. The spatial descriptors especially Jurs descriptors play important roles in predicting the compound's inhibitory activity to murine LL(c) cells, and polar interactions are the principal binding strength between compounds and murine LL(c) cells. In addition, rotatable bonds in molecules and molar refractivity of the compounds will markedly affect the compounds' inhibitory activity.
AuthorsLi Lin, Wei-Qi Lin, Jian-Hui Jiang, Guo-Li Shen, Ru-Qin Yu
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci) Vol. 25 Issue 2-3 Pg. 245-54 (Jun 2005) ISSN: 0928-0987 [Print] Netherlands
PMID15911220 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acridines
  • Antineoplastic Agents
Topics
  • Acridines (chemistry, pharmacology)
  • Algorithms
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Cell Line, Tumor
  • Inhibitory Concentration 50
  • Least-Squares Analysis
  • Models, Chemical
  • Quantitative Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: